Growth Metrics

Ligand Pharmaceuticals (LGND) Current Leases (2016 - 2025)

Historic Current Leases for Ligand Pharmaceuticals (LGND) over the last 14 years, with Q3 2025 value amounting to $1.1 million.

  • Ligand Pharmaceuticals' Current Leases rose 215.76% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 215.76%. This contributed to the annual value of $1.3 million for FY2024, which is 20878.05% up from last year.
  • Latest data reveals that Ligand Pharmaceuticals reported Current Leases of $1.1 million as of Q3 2025, which was up 215.76% from $1.1 million recorded in Q2 2025.
  • In the past 5 years, Ligand Pharmaceuticals' Current Leases registered a high of $5.4 million during Q1 2021, and its lowest value of $410000.0 during Q4 2023.
  • For the 5-year period, Ligand Pharmaceuticals' Current Leases averaged around $1.5 million, with its median value being $1.1 million (2025).
  • Per our database at Business Quant, Ligand Pharmaceuticals' Current Leases plummeted by 8333.33% in 2021 and then surged by 20878.05% in 2024.
  • Ligand Pharmaceuticals' Current Leases (Quarter) stood at $1.4 million in 2021, then tumbled by 49.4% to $715000.0 in 2022, then crashed by 42.66% to $410000.0 in 2023, then soared by 208.78% to $1.3 million in 2024, then fell by 13.98% to $1.1 million in 2025.
  • Its Current Leases stands at $1.1 million for Q3 2025, versus $1.1 million for Q2 2025 and $859000.0 for Q1 2025.